Dr. Matthew Gregory Heavner, MD

In 2023, Dr. Matthew Gregory Heavner, MD had a list price for antineoplastic hormone therapy, chronic care, and retroperitoneal ultrasound that was lower than the list prices billed to Medicare by 95% of providers in related specialties within Maryland. Actual amounts paid by patients can vary widely depending on a number of factors, including insurance coverage. A lower list price, however, might mean lower fees when paying without insurance.

In 2023, Dr. Matthew Gregory Heavner, MD had a list price for blood draw, blood draw for lab tests, core needle prostate biopsy, hormone therapy, phlebotomy for lab tests, prostate biopsy, prostate punch biopsy, and venipuncture (phlebotomy) that was lower than the list prices billed to Medicare by 90% of providers in related specialties within Maryland. Actual amounts paid by patients can vary widely depending on a number of factors, including insurance coverage. A lower list price, however, might mean lower fees when paying without insurance.

In 2013, among providers in related specialties within Maryland, Dr. Matthew Gregory Heavner, MD performed more endoscopy, post void residual study, potassium sensitivity test, and urologic procedures procedures for Medicare patients than 75% of them and he also had a list price for cystoscopic bladder stone removal without fragmentation, cystoscopic stone removal, cystoscopy with foreign body removal, cystoscopy with ureteral stent placement, cystoscopy with ureteral stent removal, cystoscopy with urethral stone removal, diagnostic cystoscopy, hospital care, inpatient care, inpatient hospital care (for patient admitted to hospital), post void residual study, ureteral stent placement, and uroflowmetry that was lower than the list prices billed to Medicare by 75% of them. Actual amounts paid by patients can vary widely depending on a number of factors, including insurance coverage. A lower list price, however, might mean lower fees when paying without insurance.